Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 7 | |
Hold | 10 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in JPY
The 15 analysts offering 12 month price targets for Takeda Pharmaceutical Co Ltd have a median target of 4,600.00, with a high estimate of 5,900.00 and a low estimate of 4,200.00. The median estimate represents a 7.91% increase from the last price of 4,263.00.
High | 38.4% | 5,900.00 |
Med | 7.9% | 4,600.00 |
Low | -1.5% | 4,200.00 |
Dividends in JPY
Div growth (TTM) | 4.44% |
---|
More ▼
Earnings history & estimates in JPY
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | +173.09% |
More ▼
Revenue history & estimates in JPY
Average growth rate | +3.65% |
Average growth rate | +6.87% |
More ▼